ArticlePediatric cardiology2026
Utility of the Frontal-Plane QRS-T Angle in a Real-World Screening Population, for Identification of Hypertrophic Cardiomyopathy.
Article in Pediatric cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The frontal QRS-T angle, derived from a standard 12-lead electrocardiogram (ECG), quantifies the relationship between ventricular depolarization and repolarization. Although a widened angle has been associated with myocardial disarray and arrhythmic risk, its diagnostic utility for detecting hypertrophic cardiomyopathy (HCM) in children, adolescents, and young adults has not been well established. We analyzed 6,128 participants aged ≤ 30 years from the Heartfelt community cardiovascular screening program. HCM was defined as septal or posterior wall thickness ≥ 2.5 SD above the mean for body-surface area in pediatric participants or ≥ 15 mm in adults. In a secondary analysis, the ≥ 15 mm threshold was applied irrespective of age. Electrocardiographic variables were evaluated using logistic regression and receiver operating characteristic (ROC) analyses. Among the 6,128 screened participants, 162 met criteria for HCM. Compared with unaffected individuals, participants with HCM were younger and had shorter PR intervals, QRS durations, and QTc values (all p < 0.001). The frontal QRS-T angle did not differ significantly between groups (23° [12-34] vs 24° [14-36]; p = 0.175) and demonstrated poor discriminatory performance (AUC 0.47; 95% CI 0.43-0.51). Findings were similar in the secondary analysis applying the ≥ 15 mm threshold across all ages (AUC 0.43; p = 0.67). In this large cohort of young community-screened participants, the frontal QRS-T angle did not distinguish individuals with hypertrophic cardiomyopathy. These findings suggest that adult-derived electrocardiographic thresholds may not be directly applicable to pediatric or athletic populations and highlight the need for age-specific ECG screening criteria.
Indexed as
Identifiers
42313125What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.